Soroush Zarehparvar Moghadam
Mashhad University of Medical Sciences
H-index: 6
Asia-Iran
Top articles of Soroush Zarehparvar Moghadam
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Complete Resolution of Locally Advanced Prostate Cancer After Molecular Endoradiotherapy With 177Lu-PSMA | Clinical Nuclear Medicine | Mohsen Beheshti Reza Vali Soroush Zarehparvar Moghadam HamidReza Amini Masoumeh Hakiminejad | 2024/3/25 |
Combination of peptide receptor radionuclide therapy and immune checkpoint inhibitor in metastatic Merkel cell carcinoma | Johannes Zellmer Lena Vomacka Guido Boening Franz Josef Gildehaus Erik Mille | 2018/5/1 | |
Free TcO4− in 99mTc-PSMA Scan: A Case Report and Review of an Old Pitfall in the New Era of Modern Imaging | Clinical Nuclear Medicine | Pegah Sahafi Kamran Aryana Soroush Zarehparvar Moghadam Kayvan Sadri Emran Askari | 2022/5/11 |
Peptide receptor radionuclide therapy in merkel cell carcinoma: a comprehensive review | Emran Askari Soroush Zarehparvar Moghadam Damian Wild Ebrahim Delpassand Sergio Baldari | 2023/3/1 | |
Efficacy, safety and prognostic factors affecting overall survival among metastatic prostate cancer patients undergoing treatment with 177Lu-PSMA-617: a single center study | Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) | Soroush Zarehparvar Moghadam Emran Askari Ghasemali Divband Sara Shakeri Kamran Aryana | 2022/7/1 |
[68Ga] Ga-PSMA-11 PET/CT for staging and patient management of high-risk prostate cancer: A single-center experience from Iran | Iranian Journal of Nuclear Medicine | Sara Shakeri Emran Askari Soroush Zarehparvar Fatemeh Farahmandfar Nasim Norouzbeigi | 2022/1/1 |
99mTc-PSMA Left Behind: a Call for Collaboration | Nuclear Medicine and Molecular Imaging | Soroush Zarehparvar Moghadam Emran Askari Kamran Aryana | 2022/8 |
After two consecutive rises in PSA level following treatment with 177Lu-PSMA-617 in mCRPC patients, is there any chance for PSA response with an additional cycle? A … | Hadis Mohammadzadeh Kosari Emran Askari Soroush Zarehparvar Moghadam Kamran Aryana | 2022/6/1 | |
Long-term Durable Response after Treatment with 177Lu-PSMA Therapy in Combination with Enzalutamide | Journal of Clinical and Medical Images Case Reports | Soroush Zarehparvar Moghadam Emran Askari Narjess Ayati Ghasemali Divband Kamran Aryana | 2022/11 |
Factores pronósticos de eficacia y seguridad que afectan a la supervivencia global de los pacientes con cáncer de próstata metastásico sometidos a tratamiento con [177Lu] Lu … | Revista Española de Medicina Nuclear e Imagen Molecular | S Zarehparvar Moghadam E Askari G Divband S Shakeri K Aryana | 2022/7/1 |
Amino acid extravasation: a rare red flag to keep in mind during peptide receptor radioligand therapy (PRRT) with [177Lu] Lu-DOTATATE | Nucl. Med. Rev. Cent. East. Eur | Ghasemali Divband Seyed Hootan Alavi Zohre Adinehpour Forough Kalantari S Zarehparvar Moghadam | 2022 |
68Ga-FAPI-46 PET/CT in a metastatic castration-resistant prostate cancer patient with low PSMA expression | Clinical Nuclear Medicine | Kamran Aryana Reyhaneh Manafi-Farid Hamidreza Amini Ghasemali Divband Soroush Zarehparvar Moghadam | 2022/11/1 |
Fact Checking on 177Lu Prostate-Specific Membrane Antigen Nephrotoxicity | American Journal of Roentgenology | Emran Askari Soroush Zarehparvar Moghadam Kamran Aryana | 2020/7 |
Medical Event: Accidental Oral Administration of: 177: Lu-PSMA to a Patient With Hyperthyroidism | Clinical Nuclear Medicine | Soroush Zarehparvar Moghadam Atena Aghaee Mohamad Esmatinia Navid Nateghi Kamran Aryana | 2020/6/1 |
Whole-Body 177Lu–Prostate-Specific Membrane Antigen Scan Pattern With Excess Free 177Lu-Chloride in a Metastatic Castration-Resistant Prostate Cancer Patient | Clinical Nuclear Medicine | Emran Askari Soroush Zarehparvar Moghadam Ghasemali Divband Kamran Aryana | 2020/10/1 |
Spurious lung perfusion ventilation defect on planar ventilation-perfusion scan detected by SPECT imaging | Iranian Journal of Nuclear Medicine | Fatemeh Farahmandfar Sara Shakeri Toktam Masoudi Soroush Zarrehparvar Moghadam Ramin Sadeghi | 2020 |
Co-Authors
